Integration after psilocybin: what the memory research supports, and what it doesn't
Memory reconsolidation is real science and a contested one. Here is what the studies show, what is still theory, and the reflective practice I built on it for psychedelic integration.
By Maya Allan
Something happened during your journey. A belief cracked. A memory surfaced that you hadn't thought about in twenty years. A knowing arrived, not an idea but a knowing, that you'd been carrying something that didn't belong to you.
You came back. You told a friend. Maybe you wrote it down.
A week later, the old pattern was back. The same reactivity. The same story. The insight was still there, sort of, like a photograph of a meal you once ate.
This is the integration problem. Most writing about psychedelic integration describes practices. Very little of it says which parts rest on research, which on clinical theory, and which on the writer's own view. I want to do that here, because the honest version is more useful than the confident one.
Substantially revised September 2026 to distinguish published research, clinical theory, and my interpretation.
How to read this article
I'm an author and educator, not a clinician or a researcher. My book, Psilocybin Integration Guide, is about reflection after an experience, and this article sets out the reasoning behind the reflective practice it proposes, including where the evidence for that reasoning stops. Throughout, I label claims three ways:
- Research. A published study or review. Numbered and listed at the end so you can check it.
- Clinical theory. A model that therapists use and have written about, supported by case reports and argument rather than controlled trials.
- My interpretation. What I take from the above and propose for reflection after a psilocybin experience. This is the part you should hold most loosely, and it is also the part I most want to be useful.
The most common integration mistake
My interpretation, drawing on clinical theory.
When something opens during a journey, the instinct afterward is to hold tightly to the insight and discard the old belief. The mental move goes: "I finally saw the truth. I am loveable, safe, enough, whatever it was. The old story was false. Replace it."
Call this the replacement model. It treats belief change like overwriting a file: delete the wrong one, save the right one, done.
Coherence Therapy, a clinical approach developed by Bruce Ecker and colleagues, argues that durable change does not come from replacing a belief but from a specific kind of contradiction, held in a specific way [3]. That is a clinical claim about how change happens in the therapy room. Whether the brain literally works this way is a separate question, and it is the question the next section is about.
What the research shows
Research.
In 2000, Nader, Schafe and LeDoux reported that in rats, a consolidated fear memory became vulnerable again when it was reactivated: blocking protein synthesis in the amygdala shortly after the memory was recalled impaired the memory afterward [1]. This is the origin of the term reconsolidation. A memory that has been retrieved can, under some conditions, re-enter a changeable state before it is stored again.
That finding has been replicated and extended in animal work many times. The question that matters for integration is whether the same thing happens in people, and whether it can be used.
The best-known human test is a 2010 study by Schiller and colleagues, in which extinction training delivered inside a window after a reminder appeared to prevent the return of a conditioned fear response [2]. That result was widely cited. In 2020, a verification report that re-analysed the original data and attempted to confirm the findings did not confirm them [4]. A 2018 critical review of the whole human literature concluded that findings are inconsistent, that alternative explanations have not been ruled out, and that reconsolidation in humans remains, in the authors' words, a viable but hotly contested explanation for some changes in memory expression [5].
So the honest summary is this. In animals, reconsolidation is an established phenomenon. In people, there is real evidence and real dispute. The evidence reviewed here does not establish that an emotional belief is literally rewritten at the neural level during post-psilocybin integration.
The clinical theory
Clinical theory.
Ecker's model proposes that for an emotional schema (a belief like "I am too much") to lose its grip, three things have to happen close together [3]:
- The old schema is activated. Felt, not just thought about.
- A contradictory lived experience is active at the same time. Not an idea or a mantra. An actual felt experience that the schema would say is impossible.
- The two are held together, at the same moment, rather than one after the other.
Ecker calls this a juxtaposition experience. In 2015, Lane, Ryan, Nadel and Greenberg published a target article in Behavioral and Brain Sciences proposing that many forms of psychotherapy produce change through this kind of memory updating, and the article drew dozens of commentaries, some supportive and some sharply critical [6].
Clinical theory can be useful before it is proven, and it can be wrong in the details. The three-step sequence is a hypothesis about mechanism, supported by clinical reports and by the animal science, not a protocol that has been validated in controlled trials of integration.
What the psilocybin research adds
Research.
Four lines of work are relevant, and none of them tested an integration practice.
A model of relaxed beliefs. Carhart-Harris and Friston's REBUS model proposes that psychedelics relax the precision of high-level beliefs, allowing information that those beliefs normally suppress to come through [7]. This is an influential theoretical framework. It is not a finding, and it is still being tested.
Plasticity in animals and cells. Ly and colleagues showed that several psychedelics increase dendritic growth and synapse formation in cultured neurons, rats and flies [8]. Shao and colleagues imaged mouse frontal cortex and found that a single dose of psilocybin increased dendritic spine density by roughly ten percent within a day, persisting a month later [9]. These are striking results. They are also animal and in-vitro results, and whether the same plasticity underlies lasting change in people has not been established.
What patients describe. In interviews six months after psilocybin for treatment-resistant depression, twenty patients described two shifts: from disconnection to connection, and from avoiding emotion to accepting it [10]. That is a small, qualitative study, and it describes what people said, not why.
Brain network changes after treatment. Daws and colleagues found that psilocybin therapy for depression was followed by increases in brain network integration that correlated with the antidepressant response [11]. Again, this is about the treatment, not about any practice done afterward.
And integration itself? A 2022 concept analysis found many definitions of psychedelic integration, a wide range of practices, and very few outcome studies [12]. Two 2024 reviews reach the same place from the clinical side. A systematic review of psilocybin-assisted psychotherapy trials for depression found substantial heterogeneity in the psychotherapy protocols and concluded that no validated, universally agreed protocol exists [13]. A systematised review of the therapeutic frameworks used in integration sessions found no controlled comparison between integration approaches and insufficient evidence that any particular framework improves outcomes [14]. Integration is under-researched relative to how much is written about it. That includes what I write.
My interpretation. Taken together, these findings are consistent with the possibility of a period of increased flexibility after psilocybin, but they do not establish a specific post-psilocybin integration window, and they do not tell us which practices, if any, improve outcomes. What to do in the weeks after an experience is, for now, judgement, and this article is one person's.
Why this matters for psychedelic integration
My interpretation.
A psilocybin journey often provides the raw material for the second of Ecker's three conditions: the contradictory lived experience. People don't just think "I am loved"; they feel it, in a way they have never felt before. If the juxtaposition model is right, that felt sense is exactly the kind of experience the model says the old belief needs to meet.
But most integration practice, in my reading of it, skips the first and third conditions.
Skipping the first. Everyone wants to stay in the afterglow and avoid the old belief. The old belief is painful. Activating it feels like going backwards. So people write about the insight and leave the part of themselves that still believes the old story untouched. If the model is right, nothing has been brought into contact with anything.
Skipping the third. The replacement model says "the old belief was false, the new one is true." That is sequential. It banishes the old belief rather than holding it beside the new experience. If the model is right, that is the wrong shape.
I want to be clear about the "if." I find the model persuasive and built a reflective practice on it. I cannot tell you it is proven.
What integration can look like
My interpretation.
You sit down with a specific moment from your journey when the new experience was alive. Not an idea about it. A concrete moment. You let yourself feel it again, at whatever intensity is available.
Then, gently, you bring in the old belief. The one that used to run things. You don't argue with it. You don't tell it it's wrong. You let it be present, right alongside the new experience.
You stay there. Maybe for ninety seconds. Maybe for five minutes.
If something shifts in the holding of both, it may be subtle rather than dramatic. The old belief doesn't vanish. It may get quieter, softer around the edges; you may notice you can't quite remember why it felt so true before. I read that as the two experiences being held together long enough to be compared. Whether it is reconsolidation in the technical sense, I can't say, and as of this writing neither can anyone.
I don't have evidence that this is more durable than journaling, affirmation, or another journey. I offer it because it follows from a coherent clinical model, it costs nothing, and it makes a prediction you can check yourself: if the old belief goes quiet without you arguing it down, something has shifted.
Practices I suggest
My interpretation.
-
Specific memory over abstract idea. Don't work with "I felt love." Work with "when I looked at my hands and they weren't my hands, and I knew I was safe." Specificity is what makes it an experience rather than a slogan.
-
Felt sense, not thought sense. If you're narrating what happened, you're describing it. If you can feel even a faint trace of it, that is where I think the work is.
-
Short sessions, spaced out. I suggest ten or fifteen minutes, a few times over the weeks after a journey, rather than long sittings. I have no data that this beats an hour of journaling, and journaling can be the vehicle for it, if the writing brings you back into the felt experience rather than around it.
-
Curiosity, not prosecution. The old belief was protecting something once. Treating it like an enemy tends to put the nervous system on guard, and if the model is right, a guarded state is not one in which an old belief opens.
Practices I think work against it
My interpretation.
-
Mantra affirmations. "I am enough, I am enough, I am enough" rehearses the new belief on its own. If the juxtaposition model is right, the new belief without the old one present is the wrong shape. Affirmations may still help people in other ways; I'm only saying they are not this.
-
Spiritual bypass. "That old story wasn't even real, it was just ego." This declines to activate the old schema at all and replaces it with a philosophical flourish. It feels good. In my view it changes little.
-
Another journey before this one has settled. Psychedelics can keep opening new experiences. Without reflective time between them, my concern is that the experiences pile up and the patterns stay. There is also a plain safety point here: repeated dosing without settled time between is not something the research supports, and it is not something I recommend.
A tool for this, if it's useful
I built a free Integration Reflection tool on this site that walks through the move described above: name the old pattern, name the new experience, hold both at once, notice what shifts. It's AI-guided, so you can use it at 2 a.m. after a journey or three weeks later when something surfaces. It doesn't tell you what your experience means. It holds the frame so you can find that yourself. It is free; keeping a session as a PDF costs $9.99.
The framework, applied to forty specific journey scenarios, is in my book, Psilocybin Integration Guide. If your journey included a loss of the sense of self, the ego dissolution scenario on this site walks through that experience specifically, with the same sourcing standard as this article.
What I'd want you to take from this
The insight is not the whole work. Something has to be done with it afterward, and the something I propose is holding the new experience and the old belief together, with care, more than once. That is my interpretation of a promising and contested area of science. I'd ask you to hold it the way I'd want you to hold any belief: activated, examined, and open to contradiction.
References
Numbered in order of first citation. Items 1, 2, 4 and 5 concern memory reconsolidation in general; 3 and 6 are clinical theory; 7 to 14 concern psilocybin and integration.
- Nader, K., Schafe, G. E., & LeDoux, J. E. (2000). Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature, 406, 722–726. doi:10.1038/35021052
- Schiller, D., Monfils, M.-H., Raio, C. M., Johnson, D. C., LeDoux, J. E., & Phelps, E. A. (2010). Preventing the return of fear in humans using reconsolidation update mechanisms. Nature, 463, 49–53. doi:10.1038/nature08637 (An addendum was published in 2018.)
- Ecker, B., Ticic, R., & Hulley, L. (2012). Unlocking the Emotional Brain: Eliminating Symptoms at Their Roots Using Memory Reconsolidation. Routledge. (Clinical theory.)
- Chalkia, A., Van Oudenhove, L., & Beckers, T. (2020). Preventing the return of fear in humans using reconsolidation update mechanisms: A verification report of Schiller et al. (2010). Cortex, 129, 510–525. Open access via PubMed Central
- Elsey, J. W. B., Van Ast, V. A., & Kindt, M. (2018). Human memory reconsolidation: A guiding framework and critical review of the evidence. Psychological Bulletin, 144(8), 797–848. PubMed 29792441
- Lane, R. D., Ryan, L., Nadel, L., & Greenberg, L. (2015). Memory reconsolidation, emotional arousal, and the process of change in psychotherapy: New insights from brain science. Behavioral and Brain Sciences, 38, e1, with open peer commentary. Cambridge Core (Theory, with debate.)
- Carhart-Harris, R. L., & Friston, K. J. (2019). REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics. Pharmacological Reviews, 71(3), 316–344. doi:10.1124/pr.118.017160 (Theoretical model.)
- Ly, C., et al. (2018). Psychedelics promote structural and functional neural plasticity. Cell Reports, 23(11), 3170–3182. doi:10.1016/j.celrep.2018.05.022 (Cells, rats, flies.)
- Shao, L.-X., et al. (2021). Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron, 109(16). doi:10.1016/j.neuron.2021.06.008 (Mice.)
- Watts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R. (2017). Patients' accounts of increased "connectedness" and "acceptance" after psilocybin for treatment-resistant depression. Journal of Humanistic Psychology, 57(5), 520–564. doi:10.1177/0022167817709585 (Qualitative, 20 patients.)
- Daws, R. E., et al. (2022). Increased global integration in the brain after psilocybin therapy for depression. Nature Medicine, 28, 844–851. doi:10.1038/s41591-022-01744-z
- Bathje, G. J., Majeski, E., & Kudowor, M. (2022). Psychedelic integration: An analysis of the concept and its practice. Frontiers in Psychology, 13, 824077. doi:10.3389/fpsyg.2022.824077
- Chisamore, N., et al. (2024). Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review. Journal of Psychiatric Research. PubMed 38850581
- Thal, S. B., et al. (2024). Therapeutic frameworks in integration sessions in substance-assisted psychotherapy: A systematised review. Clinical Psychology & Psychotherapy. doi:10.1002/cpp.2945
About the author
Maya Allan is an author and educator. She writes non-clinical, educational resources for psilocybin integration, post-journey reflection and self-inquiry, including Psilocybin Integration Guide. She is not a clinician or a researcher, and nothing on this site is medical or therapeutic advice. The methods behind the site's reflection tools, and their originators, are credited on the Methods & Attributions page.
This article is a reflection aid, not therapy. It is not a substitute for a trauma-informed professional, or for a trusted integration specialist when your experience was heavy. Don't use the reflection tool during an active psychedelic experience; a trusted person will serve you better in that state than any tool.
If you're in crisis, please call or text 988 (Suicide & Crisis Lifeline in the US), or your local emergency number.